Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma
Public ClinicalTrials.gov record NCT00250861. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase II Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for CD20 Positive Aggressive Non-Hodgkin's Lymphoma Following High Dose Therapy With Autologous PBSC Rescue
Study identification
- NCT ID
- NCT00250861
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- US Oncology Research
- Industry
- Enrollment
- 110 participants
Conditions and interventions
Conditions
Interventions
- Aldesleukin Drug
- Rituximab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2005
- Primary completion
- Jul 31, 2007
- Completion
- Jul 31, 2007
- Last update posted
- Apr 20, 2008
2005 – 2007
United States locations
- U.S. sites
- 21
- U.S. states
- 9
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rocky Mountain Cancer Center-Midtown | Denver | Colorado | 80218 | — |
| Hematology Oncology Associates of IL | Chicago | Illinois | 60611 | — |
| Cancer Care & Hematology Specialists of Chicagoland | Niles | Illinois | 60714 | — |
| Minnesota Oncology Hematology, PA | Minneapolis | Minnesota | 55404 | — |
| Kansas City Cancer Centers-Central | Kansas City | Missouri | 64111 | — |
| Greater Dayton Cancer Center | Kettering | Ohio | 45409 | — |
| Cancer Centers of the Carolinas | Greenville | South Carolina | 29615 | — |
| Texas Cancer Center | Arlington | Texas | 76014 | — |
| Texas Cancer Center at Medical City | Dallas | Texas | 75230 | — |
| El Paso Cancer Treatment Ctr | El Paso | Texas | 79915 | — |
| San Antonio Tumor & Blood Clinic | Fredericksburg | Texas | 78624 | — |
| Texas Oncology, PA | Garland | Texas | 75042 | — |
| Longview Cancer Center | Longview | Texas | 75601 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Fairfax Northern VA Hem-Onc PC | Fairfax | Virginia | 22031 | — |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | — |
| Onc and Hem Associates of SW VA, Inc. | Salem | Virginia | 24153 | — |
| Puget Sound Cancer Center-Edmonds | Edmonds | Washington | 98026 | — |
| Pudget Sound Cancer Center-Seattle | Seattle | Washington | 98133 | — |
| Cancer Care Northwest-North | Spokane | Washington | 99218 | — |
| Yakima Valley Mem Hosp/North Star Lodge | Yakima | Washington | 98902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00250861, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2008 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00250861 live on ClinicalTrials.gov.